Experience

Hunniwell Lake Ventures

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Managing Partner

  • Jul 2019 - Present

  Hunniwell invests in some of the fastest growing segments of the medical device space, including but not limited to surgical instruments and devices employing RF, ultrasonic and laser technologies, including advanced laparoscopy/endoscopy, visualization, surgical robotics and wound management/tissue regeneration. It also has a keen interest in innovative diagnostic and therapeutic devices for Pulmonology (Lungs), Gastroenterology (Stomach & Intestines) and Hepatology (Liver). Hunniwell provides entrepreneurs with a longer runway to develop a more complete portfolio of products before monetizing their innovations. We leverage our entrepreneurial spirit, operational experience and global networks to help companies achieve higher profitability earlier, through improved market access, greater capital efficiency in R&D, and lower manufacturing costs. Our investments range from companies in the pre-revenue to late/growth stage.



Picard Medical, Inc

• United States
• Medical Equipment Manufacturing

• Board Member

  • Apr 2021 - Present

  Picard Medical Inc is a platform for the future consolidation of cardiovascular related medical device technologies Picard Medical Inc is a platform for the future consolidation of cardiovascular related medical device technologies



SynCardia Systems, LLC

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Board Member

  • Sep 2021 - Present

  Syncardia is the manufacturer of the only temporary Total Artificial Hearts (TAH) approved for commercial use by the FDA. It is also approved by CE in Europe. The TAH has been implanted in more than 2000 patients to date, with the longest implant being 6 years and 9 months. Now developing a new generation of better implants and external drivers. Syncardia is the manufacturer of the only temporary Total Artificial Hearts (TAH) approved for commercial use by the FDA. It is also approved by CE in Europe. The TAH has been implanted in more than 2000 patients to date, with the longest implant being 6 years and 9 months. Now developing a new generation of better implants and external drivers.



CoapTech

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Board Member

  • Aug 2020 - Present

  Coaptech is the developer of the FDA-approved PUMA-G system for magnetic-guided ultrasound-based placement of enteral feeding tube that will transform gastrostomy by allowing the procedure to be performed at the patient bedside instead of in a surgical suite. Coaptech is the developer of the FDA-approved PUMA-G system for magnetic-guided ultrasound-based placement of enteral feeding tube that will transform gastrostomy by allowing the procedure to be performed at the patient bedside instead of in a surgical suite.



Sloan Global LLC - an outsourced CFO, Corp Dev & Finance consultancy

• Palo Alto, California

• President

  • 2007 - Present

  • CFO & VP (Int'l Biz & Ventures), $200M Chinese pre-IPO manufacturer of surgical equipment for minimally-invasive surgery (MIS) with mix of direct and distributor sales models worldwide. • CFO, US-based medical device investment company. Evaluated and developed implementation plans for potential acquisitions of technologies & marketing businesses in the hernia mesh, tackers, trocars, scopes, and related spaces • Interim CFO, Stion Corporation (San Jose, USA) - Leading VC-invested manufacturer of thin-film (CIGS) solar panels with R&D in San Jose & Manufacturing in Mississippi. Originated potential investments (~ $100M) & JV opportunities from China & Japan. • Interim CFO, Metito Holdings (Dubai, UAE) - $2 billion MENA-based PE-invested water utility & engineering company in the Middle-East and China. Navigated negotiations, due diligence & documentation process for IFC debt financing as well as an equity investments from Mitsubishi. • Interim CFO, Integrated Memory Logic (TW:IML)(San Jose, USA) - $200M VC-invested analog mixed-signal IC design firm listed in Taiwan. Managed Finance, IR, HR & IT depts. Implemented 30% cost reduction plan & doubled P/E ratio from 9x to 15x. Evaluated two potential acquisitions. Company sold to Exar Corporation (NYSE: EXAR). • Part-time CFO, a silicon-valley advanced battery technologies start-up • Monitored investments into two globally-recognized US specialty beverage brands, a US bioengineering start-up, and a resort development project on behalf of HK & PRC-based investment companies • Lead financial due diligence, valuation, financial modeling, and bid package preparation for the McDonald's franchise in China • Member of Board of Directors - focused on compliance and financial restructuring for a small independent energy company, and an environmental technologies company